A cancer patient who was forced to pay out £3,400 per fortnight for the life-saving drug cetuximab has won his battle for funding , having previously been refused the treatment on the NHS , according to the BBC .
Originally ,the Scottish Medicines Consortium said it was not cost-effective because it could only prolong life, not cure him.
Preserving life for as long as possible should be the responsibility of the NHS , the patient is quoted as saying .
Maybe so , but under capitalism , there is always a price tag and a value placed upon a person's life . Not everyone is as fortunate as this patient was .
No comments:
Post a Comment